Novartis wins key European panel's thumbs-up for migraine drug - Nano News Online

Friday, June 1, 2018

Novartis wins key European panel's thumbs-up for migraine drug

(Reuters) - Novartis's new migraine drug Aimovig won a key recommendation from a key European panel on Friday, helping open the way for potential sales before the end of the year for a medicine the Swiss drugmaker is counting on to boost growth.


from Reuters: Health News https://ift.tt/2LRQE6q

No comments:

Post a Comment